United States
Choose your country or region:
France
Germany
Italy
Japan
United Kingdom
About
Leadership
Board of Directors
Company History
Corporate Impact and Community Relations
Our Collaborations
Contact Us
Newsroom
News & Stories
Press Releases
Multimedia
Our Tests
Cologuard®
OncoExTra™
Oncoguard® Liver
Oncotype DX®
Oncotype DX Breast DCIS Score®
Oncotype DX Breast Recurrence Score®
Oncotype DX Colon Recurrence Score®
Riskguard™
Pipeline & Data
Breast Radiation Score
Cologuard® 2.0
Colorectal Cancer Blood
LBgard® Blood Tubes
Molecular Residual Disease
Multi-Cancer Early Detection
Clinical Studies
Research
Publications & Abstracts
Exact Academy
Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Stock Information
Financial Information
Email Alerts
Contact Us
Join Our Team
×
DIGITAL NEWSROOM
Posts in:
Company
March 19, 2019
Kathleen Sebelius Appointed to Exact Sciences Board
February 27, 2019
Cologuard Helps Screen Two Million People for Colorectal Cancer
August 15, 2018
University Research Park Breaks Ground on Corporate Headquarters Building for Exact Sciences
June 26, 2018
Nurse Practitioners are Critical Source of Colorectal Cancer Screening Information for Patients, Survey Shows
June 05, 2018
Pipeline Update: Promising Advances in Early Liver Cancer Detection Shared at International Conference
January 11, 2018
Investing in our Long-Term Growth
November 20, 2017
For the Second Consecutive Year, Exact Sciences included in Deloitte’s Technology Fast 500.
November 15, 2017
Cologuard's Patient Compliance Program
November 02, 2017
Meet the people behind Cologuard: #TeamCologuard
October 30, 2017
Expansion through the Third Quarter
August 02, 2017
Continued Momentum Through the Second Quarter
June 12, 2017
Cologuard Featured as High Value Diagnostic Technology by AdvaMed
1
2
3
4
